Work

Abstract PS4-06-19: Final results of a Phase I trial of an alpha-lactalbumin (aLA) vaccine for breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-06-19

Authors: J. M. Johnson, E. E. Rhoades, H. B. Levengood, A. Ali, H. Gilmore, M. L. Kruse, E. E. Roesch, T. Onger, B. Elliott, E. Haury, C. Porvasnik, T. Young, T. Coutee, J. A. Fitzgerald, T. S. Stappenbeck, G. T. Budd

Institution: Cleveland Clinic

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129811282

Cites:

Cited by:

Related to: